{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:45:32Z","timestamp":1792035932403,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014206","name":"National Key Laboratory Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biomaterials.2025.123184","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T07:56:41Z","timestamp":1739433401000},"page":"123184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Harnessing prazosin for tumors: Liposome hybrid nanovesicles activate tumor immunotherapy via autophagy inhibition"],"prefix":"10.1016","volume":"319","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9986-1489","authenticated-orcid":false,"given":"Xinyang","family":"Xuanyuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BeiBei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofeng","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-2445","authenticated-orcid":false,"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5746-8080","authenticated-orcid":false,"given":"Zhengmao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2025.123184_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123184_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123184_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123184_bib4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1593\/neo.07475","article-title":"Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle","volume":"9","author":"Lin","year":"2007","journal-title":"Neoplasia"},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123184_bib5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.18632\/oncotarget.28010","article-title":"Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment","volume":"12","author":"Kamgar-Dayhoff","year":"2021","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123184_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jama.1977.03270370061024","article-title":"Prazosin-new hypertensive agent. A double-blind crossover study in the treatment of hypertension","volume":"237","author":"Schirger","year":"1977","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123184_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1442-2042.2000.00175.x","article-title":"Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia","volume":"7","author":"Tsujii","year":"2000","journal-title":"Int. J. Urol. : official journal of the Japanese Urological Association"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2025.123184_bib8","first-page":"10","article-title":"Prazosin but not tamsulosin sensitises PC-3 and LNCaP prostate cancer cells to docetaxel","volume":"102","author":"Spencer","year":"2018","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123184_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107905","article-title":"Small molecule enhancers of endosome-to-cytosol import augment anti-tumor immunity","volume":"32","author":"Kozik","year":"2020","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123184_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.15252\/emmm.201505421","article-title":"The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKC\u03b4-dependent inhibition of the AKT pathway","volume":"8","author":"Assad Kahn","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123184_bib11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00277-009-0704-z","article-title":"The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells","volume":"88","author":"Fuchs","year":"2009","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123184_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12032-024-02323-7","article-title":"The cytotoxic effects of prazosin, chlorpromazine, and haloperidol on hepatocellular carcinoma and immortalized non-tumor liver cells, Medical oncology","volume":"41","author":"Harris","year":"2024","journal-title":"Northwood, London, England)"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123184_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1158\/0008-5472.CAN-05-2039","article-title":"Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway","volume":"66","author":"Garrison","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123184_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/pros.20260","article-title":"Oral treatment of the TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis","volume":"64","author":"Chiang","year":"2005","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123184_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00240-003-0365-7","article-title":"Induction of anoikis by doxazosin in prostate cancer cells is associated with activation of caspase-3 and a reduction of focal adhesion kinase","volume":"32","author":"Walden","year":"2004","journal-title":"Urol. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123184_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123184_bib17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41418-019-0297-6","article-title":"Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation","volume":"26","author":"Germic","year":"2019","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123184_bib18","first-page":"1211","article-title":"Prazosin induced lysosomal tubulation interferes with cytokinesis and the endocytic sorting of the tumour antigen CD98hc, Biochimica et biophysica acta","volume":"1865","author":"Fuchs","year":"2018","journal-title":"Molecular cell research"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123184_bib19","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.apsb.2022.02.008","article-title":"Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy via inhibiting tumor-associated macrophage M2 polarization","volume":"12","author":"Zhang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123184_bib20","first-page":"597","article-title":"ROS-sensitive PD-L1 siRNA cationic selenide nanogels for self-inhibition of autophagy and prevention of immune escape","volume":"41","author":"Gao","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123184_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2023.12.032","article-title":"Autophagy-modulating biomembrane nanostructures: a robust anticancer weapon by modulating the inner and outer cancer environment","volume":"366","author":"Zhang","year":"2024","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123184_bib22","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acsnano.0c09681","article-title":"Immunogenic hybrid nanovesicles of liposomes and tumor-derived nanovesicles for cancer immunochemotherapy","volume":"15","author":"Hu","year":"2021","journal-title":"ACS Nano"},{"issue":"22","key":"10.1016\/j.biomaterials.2025.123184_bib23","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.vaccine.2021.04.021","article-title":"Efficient immunogenic peptide antigen delivery to dendritic cells using an ESCRT-mediated extracellular vesicle formation method","volume":"39","author":"Kimura","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2025.123184_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jconrel.2023.11.051","article-title":"OX40L-expressing M1-like macrophage exosomes for cancer immunotherapy","volume":"365","author":"Yu","year":"2024","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.biomaterials.2025.123184_bib25","article-title":"Lipid-hybrid cell-derived biomimetic functional materials: a state-of-the-art multifunctional weapon against tumors, Materials today","volume":"22","author":"Liu","year":"2023","journal-title":"Bio"},{"key":"10.1016\/j.biomaterials.2025.123184_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2018.09.001","article-title":"Drug nanocrystallisation within liposomes","volume":"288","author":"Li","year":"2018","journal-title":"J. Contr. Release: Official Journal of the Controlled Release Society"},{"key":"10.1016\/j.biomaterials.2025.123184_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2023.10.014","article-title":"The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments","volume":"364","author":"Van de Vyver","year":"2023","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123184_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.biomaterials.2025.123184_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115751","article-title":"Liposomes characterization for market approval as pharmaceutical products: analytical methods, guidelines and standardized protocols","volume":"236","author":"Giordani","year":"2023","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.biomaterials.2025.123184_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/17425247.2011.566552","article-title":"Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity","volume":"8","author":"Gubernator","year":"2011","journal-title":"Expet Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123184_bib31","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1016\/j.apsb.2024.03.014","article-title":"An antibiotic-free platform for eliminating persistent Helicobacter pylori infection without disrupting gut microbiota","volume":"14","author":"Lai","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123184_bib32","article-title":"Targeted sonodynamic therapy platform for holistic integrative Helicobacter pylori therapy","author":"Yin","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2025.123184_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122776","article-title":"A dendritic cell-recruiting, antimicrobial blood clot hydrogel for melanoma recurrence prevention and infected wound management","volume":"313","author":"Liu","year":"2025","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123184_bib34","article-title":"Treatment with mesenchymal stem cell-derived nanovesicle-containing gelatin methacryloyl hydrogels alleviates osteoarthritis by modulating chondrogenesis and macrophage polarization","volume":"12","author":"Pang","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123184_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103745","article-title":"Monitoring EPR effect dynamics during nanotaxane treatment with theranostic polymeric micelles","volume":"9","author":"Biancacci","year":"2022","journal-title":"Adv. Sci."},{"issue":"26","key":"10.1016\/j.biomaterials.2025.123184_bib36","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.7150\/thno.37198","article-title":"Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment","volume":"9","author":"Park","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123184_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/acs.biomac.7b01176","article-title":"EXOPLEXs: chimeric drug delivery platform from the fusion of cell-derived nanovesicles and liposomes","volume":"19","author":"Goh","year":"2018","journal-title":"Biomacromolecules"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123184_bib38","first-page":"5915","article-title":"Adaptive design of nanovesicles overcoming immunotherapeutic limitations of chemotherapeutic drugs through poliovirus receptor blockade","volume":"18","author":"Yu","year":"2024","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123184_bib39","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123184_bib40","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/acs.nanolett.9b03817","article-title":"Cancer-cell-membrane-Coated nanoparticles with a yolk-shell structure augment cancer chemotherapy","volume":"20","author":"Nie","year":"2020","journal-title":"Nano Lett."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123184_bib41","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1021\/acsnano.9b08798","article-title":"Increasing the potential interacting area of nanomedicine enhances its homotypic cancer targeting efficacy","volume":"14","author":"Zhu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123184_bib42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.actbio.2021.03.056","article-title":"Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis","volume":"127","author":"Meng","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2025.123184_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jcis.2021.02.006","article-title":"Cell membrane camouflaged bismuth nanoparticles for targeted photothermal therapy of homotypic tumors","volume":"591","author":"Ren","year":"2021","journal-title":"J. Colloid Interface Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123184_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41556-018-0244-7","article-title":"The lysosome as a cellular centre for signalling, metabolism and quality control","volume":"21","author":"Lawrence","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123184_bib45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrm4024","article-title":"Autophagy at the crossroads of catabolism and anabolism","volume":"16","author":"Kaur","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123184_bib46","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41467-018-03225-9","article-title":"Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123184_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/cdd.2014.150","article-title":"Oxidative stress and autophagy: the clash between damage and metabolic needs","volume":"22","author":"Filomeni","year":"2015","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123184_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002147","article-title":"Combination chemo-immunotherapy for pancreatic cancer using the immunogenic effects of an irinotecan silicasome nanocarrier plus anti-PD-1","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci."},{"issue":"35","key":"10.1016\/j.biomaterials.2025.123184_bib49","doi-asserted-by":"crossref","first-page":"58754","DOI":"10.18632\/oncotarget.17678","article-title":"Endoplasmic reticulum stress-mediated membrane expression of CRT\/ERp57 induces immunogenic apoptosis in drug-resistant endometrial cancer cells","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123184_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123184_bib51","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1158\/1078-0432.CCR-09-2891","article-title":"Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway","volume":"16","author":"Zitvogel","year":"2010","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123184_bib52","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2967\/jnumed.120.245290","article-title":"Imaging calreticulin for early detection of immunogenic cell death during anticancer treatment","volume":"62","author":"Kim","year":"2021","journal-title":"J. Nucl. Med. : official publication, Society of Nuclear Medicine"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123184_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"Journal for immunotherapy of cancer"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123184_bib54","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123184_bib55","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123184_bib56","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1008866","article-title":"Trial Watch: immunogenic cell death inducers for anticancer chemotherapy","volume":"4","author":"Pol","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.biomaterials.2025.123184_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123184_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102424","article-title":"Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity","volume":"24","author":"Moriya","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.biomaterials.2025.123184_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114503","article-title":"Immunogenic cell death inducer peptides: a new approach for cancer therapy, current status and future perspectives","volume":"161","author":"Aria","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2025.123184_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120545","article-title":"Intelligent MoS(2)-CuO heterostructures with multiplexed imaging and remarkably enhanced antitumor efficacy via synergetic photothermal therapy\/chemodynamic therapy\/immunotherapy","volume":"268","author":"Jiang","year":"2021","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123184_bib61","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1021\/acsnano.0c00962","article-title":"Cell-penetrating nanoparticles activate the inflammasome to enhance antibody production by targeting microtubule-associated protein 1-light chain 3 for degradation","volume":"14","author":"Zhu","year":"2020","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123184_bib62","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.immuni.2013.09.014","article-title":"TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance","volume":"39","author":"Baghdadi","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2025.123184_bib63","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2147\/IJN.S125866","article-title":"Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens","volume":"12","author":"Gao","year":"2017","journal-title":"International journal of nanomedicine"},{"key":"10.1016\/j.biomaterials.2025.123184_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2015.05.003","article-title":"Chemokine-guided cell positioning in the lymph node orchestrates the generation of adaptive immune responses","volume":"36","author":"Lian","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123184_bib65","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/imm.13497","article-title":"Lymph node stromal cells support the maturation of pre-DCs into cDC-like cells via colony-stimulating factor 1","volume":"166","author":"Wiechers","year":"2022","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123184_bib66","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The roles of CD8(+) T cell subsets in antitumor immunity","volume":"30","author":"St Paul","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"20","key":"10.1016\/j.biomaterials.2025.123184_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205108","article-title":"Identification and comprehensive Co-detection of necrotic and viable aneuploid cancer cells in peripheral blood","volume":"13","author":"Lin","year":"2021","journal-title":"Cancers"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T09:33:01Z","timestamp":1741599181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":67,"alternative-id":["S0142961225001036"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123184","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing prazosin for tumors: Liposome hybrid nanovesicles activate tumor immunotherapy via autophagy inhibition","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"123184"}}